catechin and s 8932
catechin has been researched along with s 8932 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| De, N; Gao, W; Mondal, S; Pal, A | 1 |
| Banerjee, A; Kanwar, M; Maiti, S | 1 |
Other Studies
3 other study(ies) available for catechin and s 8932
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Molecular Descriptors of Some Chemicals that Prevent COVID-19.
Topics: Adenosine Monophosphate; Alanine; Biflavonoids; Catechin; COVID-19; Humans; Hydroxychloroquine; Quantitative Structure-Activity Relationship; SARS-CoV-2 | 2021 |
Theaflavin-3'-O-gallate a Black-tea Constituent Blocked SARS CoV-2 RNA dependant RNA Polymerase Active-site with Better Docking Results than Remdesivir.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Biflavonoids; Catalytic Domain; Catechin; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; COVID-19 Drug Treatment; Drug Design; Enzyme Inhibitors; Gallic Acid; Molecular Docking Simulation; Protein Conformation; SARS-CoV-2; Structure-Activity Relationship | 2021 |